Eur J Heart Fail 24:18131815
The latest move builds on the agency's decision in September to add semaglutide and tirzepatide, active ingredients in Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, to its essential medicines list for managing type 2 diabetes in high-risk groups
Evidence can be limited, mixed, preclinical, observational, old, formulation-specific, or otherwise insufficient to support an FDA-approved indication
It works in the background to maintain consistent insulin levels and appetite suppression, regardless of your daily schedule
The Novo Nordisk Patient Assistance Program is considered a last-resort option for patients who have no other way to pay for their medication
These members were paid in exchange for their testimonials